Published Paper Details:

RetinoScopeAI is an OCT retinal prediction platform that was created using AI to deliver precise and early identification of reti-nal conditions like Choroidal Ne- ovascularization (CNV), Dia-betic Macular Edema (DME), and Drusen. It is a system that involves deep learning algo- rithms to decode high-resolution Optical Coherence Tomog- raphy (OCT) images. Such images are initially optimized by performing preprocessing on the image to remove noise and enhance the clarity of the image. Once preprocessed, the im- ages go through a trained neural network and disease-spe- cific patterns in the layers on the eye are detected. The site offers secure and easy web interface to physicians and healthcare providers. Users are able to send OCT images and get real-time results of diagnosis. The system shows the pre- dicted disease as well as the visual finding of the OCT scan. It can also give confidence scores and clinical insights to make medical decisions. RetinoScopeAI will help eliminate the reliance on manual interpretation by professionals. This reduces the human error and enhances consistency in diag- nosis. The platform aids in early detection and this aids in preventing loss of vision. It also can be used in remote and tele-ophthalmology. The automatic analysis saves time on the part of the doctors and more efficient on the screen-ing. Ret- inoScopeAI is an AI-based medical imaging company that creates better patient care. In general, the platform provides an efficient, rapid, and smart way of diagnosing and man- management of retinal diseases.